CLINICAL_TRIALS
trial_result
· 2022-02-09
Clinical Trial Update: Toripalimab With Neoadjuvant Chemotherapy for Locally Advanced Esophageal Squamous Cell Carcinoma [Phase 2]
Summary
Phase 2 trial evaluating toripalimab in combination with neoadjuvant chemotherapy for locally advanced esophageal squamous cell carcinoma.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sichuan Cancer Hospital and Research Institute | Conditions: Esophageal Squamous Cell Carcinoma | Phase 2 | Status: UNKNOWN